JPMorgan Starts ChemoCentryx (CCXI) at Overweight
Tweet
Share
E-mailGet Alerts CCXI Hot Sheet
Price: $17.07 +5.44%
Rating Summary:
4 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 7
Rating Summary:
4 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 7
Join SI Premium – FREE
JPMorgan initiates coverage on ChemoCentryx (NASDAQ: CCXI) with an Overweight. PT $16.00.
For an analyst ratings summary and ratings history on ChemoCentryx click here. For more ratings news on ChemoCentryx click here.
Shares of ChemoCentryx closed at $10.17 yesterday.
For an analyst ratings summary and ratings history on ChemoCentryx click here. For more ratings news on ChemoCentryx click here.
Shares of ChemoCentryx closed at $10.17 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Starts Aditya Birla Real Estate (ABREL:IN) at Buy
- Citi Starts Luxshare Precision (2475:HK) at Buy
- JPMorgan Upgrades PhysicsWallah Ltd (PWL:IN) to Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
